Pediatrix Medical (MD) Common Equity (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Common Equity data on file, last reported at $878.6 million in Q1 2026.

• Quarterly Common Equity rose 11.33% year-over-year to $878.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $878.6 million (up 11.33% YoY) and the FY2025 annual result came in at $865.9 million, up 13.19% from the prior year.
• Common Equity grew to $878.6 million in Q1 2026 per MD's latest filing, from $865.9 million in the prior quarter.
• Across five years, Common Equity topped out at $968.0 million in Q3 2023 and bottomed at $706.5 million in Q2 2024.
• The 5-year median for Common Equity is $858.7 million (2022), against an average of $850.6 million.
• The widest annual swing landed in 2024, when Common Equity retreated 25.03%; it then gained 21.59% in 2025.
• Tracing MD's Common Equity over 5 years: stood at $891.6 million in 2022, then retreated by 4.77% to $849.1 million in 2023, then retreated by 9.91% to $764.9 million in 2024, then gained by 13.19% to $865.9 million in 2025, then gained by 1.47% to $878.6 million in 2026.
• Per Business Quant, the three latest MD Common Equity figures stand at $878.6 million (Q1 2026), $865.9 million (Q4 2025), and $890.7 million (Q3 2025).

Peer Comparison